Distribuzione geografica
Continente #
EU - Europa 91
NA - Nord America 82
AS - Asia 51
AF - Africa 8
SA - Sud America 1
Totale 233
Nazione #
US - Stati Uniti d'America 71
IT - Italia 43
JP - Giappone 16
GB - Regno Unito 12
IN - India 12
FR - Francia 10
CA - Canada 7
NL - Olanda 7
IR - Iran 6
EG - Egitto 5
AT - Austria 3
CZ - Repubblica Ceca 3
DE - Germania 3
HK - Hong Kong 3
PK - Pakistan 3
TH - Thailandia 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
ES - Italia 2
FI - Finlandia 2
MX - Messico 2
SG - Singapore 2
ZM - Zambia 2
BE - Belgio 1
CN - Cina 1
EC - Ecuador 1
GR - Grecia 1
KR - Corea 1
LB - Libano 1
MY - Malesia 1
NG - Nigeria 1
RO - Romania 1
SA - Arabia Saudita 1
SE - Svezia 1
TW - Taiwan 1
Totale 233
Città #
Fleming Island 18
Foggia 14
Rome 8
Delhi 4
Toronto 4
Vico del Gargano 4
Bangkok 3
Faisalabad 3
Hollis Center 3
Milan 3
New York 3
Tokyo 3
Zagazig 3
Ballyclare 2
Birmingham 2
Central 2
Faremoutiers 2
Fort Collins 2
Jaipur 2
Lusaka 2
Mohali 2
Naples 2
Northwich 2
Salles-de-Barbezieux 2
Santo Domingo 2
Singapore 2
Baldwin 1
Beijing 1
Beirut 1
Bengaluru 1
Bognor Regis 1
Burlington 1
Cairo 1
Cannes 1
Charleston 1
Clarks Summit 1
Council Bluffs 1
Crawley 1
Dijon 1
Ecatepec De Morelos 1
Fort Lee 1
Genova 1
Graz 1
Guayaquil 1
Hachizuka 1
Hackensack 1
Helsinki 1
Hillsborough 1
Imaichi 1
Iztapalapa 1
Jesolo 1
Johor Bahru 1
Kansas City 1
Koto 1
Langenbach 1
Leer 1
Lethbridge 1
Long Beach 1
Lyon 1
Marco 1
Minato-ku 1
Missoula 1
Montréal 1
Morro Bay 1
Mumbai 1
Nishikicho 1
Nuremberg 1
Olsted 1
Orange 1
Oulu 1
Palmetto 1
Paris 1
Philadelphia 1
Platteville 1
Rimini 1
Roanoke 1
Rochester 1
Roda 1
Rotterdam 1
Sagamino 1
San Severo 1
Seattle 1
Seoul 1
Slagelse 1
Stamford 1
Stockholm 1
Taipei 1
Teruel 1
The Bronx 1
Turin 1
Washington 1
Totale 164
Nome #
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review, file de2a638f-dd9b-8577-e053-3705fe0aa5f3 26
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial., file de2a638e-fe9e-8577-e053-3705fe0aa5f3 22
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review, file de2a6390-aadd-8577-e053-3705fe0aa5f3 16
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?, file de2a638e-fef3-8577-e053-3705fe0aa5f3 13
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy, file de2a638f-def4-8577-e053-3705fe0aa5f3 12
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques., file de2a638f-02b9-8577-e053-3705fe0aa5f3 8
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke., file de2a638e-ffba-8577-e053-3705fe0aa5f3 7
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke, file de2a638f-d728-8577-e053-3705fe0aa5f3 7
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?, file de2a638e-fd7a-8577-e053-3705fe0aa5f3 6
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease., file de2a638f-02b7-8577-e053-3705fe0aa5f3 6
Post-stroke spasticity as a condition: a new perspective on patient evaluation, file de2a638f-d4d5-8577-e053-3705fe0aa5f3 6
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial, file de2a638e-fd7f-8577-e053-3705fe0aa5f3 5
Does Spasticity Reduction by Botulinum Toxin Type A Improve Upper Limb Functionality in Adult Post-Stroke Patients? A Systematic Review of Relevant Studies., file de2a638f-02bb-8577-e053-3705fe0aa5f3 5
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward., file de2a638f-02d0-8577-e053-3705fe0aa5f3 5
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study, file de2a638f-d551-8577-e053-3705fe0aa5f3 5
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease., file de2a6390-8295-8577-e053-3705fe0aa5f3 5
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease., file de2a638e-fd77-8577-e053-3705fe0aa5f3 4
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab., file de2a638e-fd78-8577-e053-3705fe0aa5f3 4
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke., file de2a638e-fd7b-8577-e053-3705fe0aa5f3 4
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty., file de2a638e-fd7c-8577-e053-3705fe0aa5f3 4
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies., file de2a638e-fef5-8577-e053-3705fe0aa5f3 4
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation., file de2a638e-fef6-8577-e053-3705fe0aa5f3 4
Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors., file de2a638f-02af-8577-e053-3705fe0aa5f3 4
Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy, file de2a6390-702b-8577-e053-3705fe0aa5f3 3
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms., file de2a6390-91d8-8577-e053-3705fe0aa5f3 3
Is the outcome of diagnostic nerve block related to spastic muscle echo intensity? A retrospective observational study on patients with spastic equinovarus foot, file 179a43b6-e93b-4de7-9cfa-21d7bf5927e8 2
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus?, file de2a638e-f5cc-8577-e053-3705fe0aa5f3 2
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus?, file de2a638e-fd80-8577-e053-3705fe0aa5f3 2
Current epidemiological approaches to the metabolic-cognitive syndrome., file de2a638e-ffd1-8577-e053-3705fe0aa5f3 2
Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches, file de2a638f-6077-8577-e053-3705fe0aa5f3 2
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment, file de2a638f-607d-8577-e053-3705fe0aa5f3 2
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study, file de2a6390-0889-8577-e053-3705fe0aa5f3 2
Combined effects of isokinetic training and botulinum toxin type a on spastic equinus foot in patients with chronic stroke: A pilot, single-blind, randomized controlled trial, file de2a6390-6cd6-8577-e053-3705fe0aa5f3 2
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment, file de2a6390-8538-8577-e053-3705fe0aa5f3 2
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms., file de2a6390-8756-8577-e053-3705fe0aa5f3 2
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging, file de2a6390-9982-8577-e053-3705fe0aa5f3 2
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke, file 4fa63dfd-fbfc-401b-be07-9786a775fe72 1
Late-life depression, mild cognitive impairment, and dementia: possible continuum?, file de2a638e-fb01-8577-e053-3705fe0aa5f3 1
Lifestyle-related factors in predementia and dementia syndromes., file de2a638e-fd8e-8577-e053-3705fe0aa5f3 1
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study., file de2a638f-0115-8577-e053-3705fe0aa5f3 1
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study., file de2a638f-02d4-8577-e053-3705fe0aa5f3 1
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity, file de2a638f-607a-8577-e053-3705fe0aa5f3 1
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?, file de2a638f-6910-8577-e053-3705fe0aa5f3 1
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study, file de2a6390-0250-8577-e053-3705fe0aa5f3 1
Iatrogenic nerve lesion following laparoscopic surgery. A case report, file de2a6390-21d9-8577-e053-3705fe0aa5f3 1
AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study., file de2a6390-69c7-8577-e053-3705fe0aa5f3 1
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study, file de2a6390-6fc2-8577-e053-3705fe0aa5f3 1
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach†, file de2a6390-7023-8577-e053-3705fe0aa5f3 1
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease., file de2a6390-829d-8577-e053-3705fe0aa5f3 1
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia?, file de2a6390-84b6-8577-e053-3705fe0aa5f3 1
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease, file de2a6390-875d-8577-e053-3705fe0aa5f3 1
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes, file de2a6390-87c4-8577-e053-3705fe0aa5f3 1
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging, file de2a6390-887c-8577-e053-3705fe0aa5f3 1
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure., file de2a6390-8968-8577-e053-3705fe0aa5f3 1
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity, file de2a6390-ae17-8577-e053-3705fe0aa5f3 1
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation, file de2a6390-c565-8577-e053-3705fe0aa5f3 1
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation, file de2a6391-153a-8577-e053-3705fe0aa5f3 1
Suspension of Care for Patients With Spasticity During COVID-19 Pandemic: Ethical and Medico-Legal Point of View Starting From an Italian Study, file de2a6391-1793-8577-e053-3705fe0aa5f3 1
Early botulinum toxin type a injection for post-stroke spasticity: A longitudinal cohort study, file de2a6391-1a43-8577-e053-3705fe0aa5f3 1
Focal neuropathy mimicking focal dystonia in a child: Diagnostic and rehabilitative tools, file de2a6391-1a45-8577-e053-3705fe0aa5f3 1
Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report, file de2a6391-1aee-8577-e053-3705fe0aa5f3 1
High dosage of botulinum toxin type a in adult subjects with spasticity following acquired central nervous system damage: Where are we at?, file de2a6391-1bea-8577-e053-3705fe0aa5f3 1
Totale 236
Categoria #
all - tutte 450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 450

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 1 0 0 0
2020/202115 0 0 0 0 15 0 0 0 0 0 0 0
2021/20221 0 0 0 0 0 0 0 0 0 0 0 1
2022/2023155 0 0 10 8 12 19 35 37 17 10 3 4
Totale 236